Characterized SL genes

Role in SL pathway

A. thaliana reference

P. aegyptiaca

S. hermonthica

T. versicolor

Accession (Amino acid length)

Extent of coding sequence identified

(Amino acid length, identity to A. thaliana)

D27Os*

Biosynthesis of SL precursor

AT1G03055 (264)

Full (251, 41.9%)

Partial (73, 53.6%)

Partial (232, 41.0%)

CCD7/MAX3At, RMS5Ps, D17Os, DAD3Ph

Biosynthesis of SL precursor

AT2G44990 (629)

Full (652, 55.3%)

Partial (533, 45.2%)

Fragments

CCD8/MAX4At, RMS1Ps, D10Os, DAD1Ph

Biosynthesis of carlactone

AT4G32810 (570)

Full (563, 60.3%)

Partial (214, 67.8%)

Partial (279, 65.7%)

MAX1At

Conversion to bioactive SL

AT2G26170 (522)

Full (526, 68.5%)

Full (523, 65.8%)

Full (478, 65.5%)

MAX2At, RMS4Ps, D3Os

Mediates signaling (Both SL and karrikin signals)

AT2G42620 (693)

Full (709, 55.9%)

Full (703, 56.6%)

Partial (296, 50.3%)

D14Os, DAD2Ph

Signal perception (SL binding)

AT3G03990 (267)

Full (266, 77.2%)

Partial (180, 76.8%)

Full (273, 62.1%)

KAI2At

Homolog of D14. Related to karrikin signaling.

AT4G37470 (270)

Full (270, 75.2%)

Full (271, 75.6%)

Full (272, 73.9%)

PDR12At, PDR1Ph

SL transport

AT1G15520 (1423)

Full (1428, 69.0%)

Full (1440, 68.3%)

Full (1491. 67.2%)